Mild Cognitive Impairment: International Perspectives / Edition 1

Mild Cognitive Impairment: International Perspectives / Edition 1

ISBN-10:
1138006254
ISBN-13:
9781138006256
Pub. Date:
08/07/2015
Publisher:
Taylor & Francis
ISBN-10:
1138006254
ISBN-13:
9781138006256
Pub. Date:
08/07/2015
Publisher:
Taylor & Francis
Mild Cognitive Impairment: International Perspectives / Edition 1

Mild Cognitive Impairment: International Perspectives / Edition 1

$45.99
Current price is , Original price is $45.99. You
$45.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time.

This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI. Clinical investigators initially defined mild cognitive impairment (MCI) as a transitional condition between normal aging and the early stages of Alzheimer's disease (AD). Because the prevalence of AD increases with age and very large numbers of older adults are affected worldwide, these clinicians saw a pressing need to identify AD as early as possible. It is at this very early stage in the disease course that treatments to slow the progress and control symptoms are likely to be most effective.

Since the first introduction of MCI, research interest has grown exponentially, and the utility of the concept has been investigated from a variety of perspectives in different populations of interest (e.g., clinical samples, volunteers, population-based screening) in many different countries. Much variability in findings has resulted. Although it has been acknowledged that the differences observed between samples may be 'legitimate variations', there has been no attempt to understand what it is we have learned about MCI (i.e., common features and differences) from each of these perspectives.

This book brings together information about MCI in different populations from around the world. Mild Cognitive Impairment will be an important resource for any clinician, researcher, or student involved in the study, detection, treatment, and rehabilitation of people with MCI.


Product Details

ISBN-13: 9781138006256
Publisher: Taylor & Francis
Publication date: 08/07/2015
Series: Studies on Neuropsychology, Neurology and Cognition
Pages: 336
Product dimensions: 6.12(w) x 9.19(h) x (d)

About the Author

Holly A. Tuokko was a Professor in the Department of Psychology and Institute on Aging and Lifelong Health at the University of Victoria. She was awarded Senior Investigator status through the Canadian Institutes of Health Research, Institute of Aging (2002–2007), for her program of research on mental health and aging.

David F. Hultsch was a Professor of Psychology at the University of Victoria from 1984 onward, with a major research focus on cognition and aging. He was a founder of the journal Aging, Neuropsychology, and Cognition, serving as co-editor for 10 years.

Table of Contents

About the editors

List of contributors

From the series editor

Introduction to the Classic Edition

Part I

Introduction

  1. An overview of mild cognitive impairment

HOLLY A. TUOKKO AND IAN MCDOWELL

Part II

General Population Research on MCI

2 The PAQUID study

COLETTE FABRIGOULE, PASCALE BARBERGER-GATEAU, AND JEAN-FRANÇOIS DARTIGUES

3 Cognitive impairment in elderly persons without dementia: Findings from the Kungsholmen Project

KATIE PALMER, LARS BACKMAN, BRENT J. SMALL, AND LAURA FRATIGLIONI

4 Population levels of mild cognitive impairment in England and Wales

JANE FLEMING, FIONA E. MATTHEWS, MARK CHATFIELD, AND CAROL BRAYNE

5 The Melbourne Aging Study

ALEXANDER COLLIE, PAUL MARUFF, DAVID G. DARBY, COLIN MASTERS, AND JON CURRIE

Part III

Specific Samples

6 Mild cognitive impairment in the Religious Orders Study

    ROBERT S. WILSON, NEELUM T. AGGARWAL, AND DAVID A. BENNETT

7 A perspective from the Mayo Clinic

    GLENN SMITH, MARY MACHULDA, AND KEJAL KANTARCI

8 Prediction of probable Alzheimer's disease: The Sunnybrook Memory Study

    MARY C. TIERNEY

9 Studies in the Leipzig Memory Clinic: Contribution to the concept of mild cognitive impairment

    HENRIKE WOLF AND HERMANN-JOSEF GERTZ

    Part IV

    Interventions

10 Emerging pharmacological therapies for mild cognitive impairment

    HOWARD CHERTKOW

    11 Cognition-based therapies and mild cognitive impairment

    ROBERT T. WOODS AND LINDA CLARE

12 Combined therapies in mild cognitive impairment

    KEVIN PETERS AND GORDON WINOCUR

    Part V

    Summary and Future Directions

13 The future of mild cognitive impairment

HOLLY A. TUOKKO AND DAVID F. HULTSCH

Author index

Subject index

From the B&N Reads Blog

Customer Reviews